Greggs boss says there is ‘no doubt’ weight loss jabs are impacting business

GLP-1s are a class of medications that mimic the hormone which suppresses appetite (Chris Radburn/PA) - (PA Wire)

The boss of Greggs has said there is “no doubt” appetite-suppressing medication is having an impact on the bakery chain’s business as it introduces healthier options on its menu.

Chief executive Roisin Currie said: “What we’ve been seeing is people are looking for smaller portions, people are looking for information on areas such as protein and fibre, and therefore we’re making sure that in the breadth of our range we can offer those choices to customers.”